- Home
- KRYS vs IRT Comparison
KRYS vs IRT Comparison
Compare KRYS & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- IRT
- Stock Information
- Founded
- KRYS 2015
- IRT 2009
- Country
- KRYS United States
- IRT United States
- Employees
- KRYS N/A
- IRT N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- IRT Real Estate Investment Trusts
- Sector
- KRYS Health Care
- IRT Real Estate
- Exchange
- KRYS Nasdaq
- IRT Nasdaq
- Market Cap
- KRYS 4.7B
- IRT 3.8B
- IPO Year
- KRYS 2017
- IRT 2013
- Fundamental
- Price
- KRYS $196.65
- IRT $16.35
- Analyst Decision
- KRYS Strong Buy
- IRT Buy
- Analyst Count
- KRYS 9
- IRT 7
- Target Price
- KRYS $214.22
- IRT $22.14
- AVG Volume (30 Days)
- KRYS 316.5K
- IRT 3.3M
- Earning Date
- KRYS 11-03-2025
- IRT 10-29-2025
- Dividend Yield
- KRYS N/A
- IRT 4.16%
- EPS Growth
- KRYS 275.72
- IRT N/A
- EPS
- KRYS 6.66
- IRT 0.09
- Revenue
- KRYS $373,164,000.00
- IRT $662,924,000.00
- Revenue This Year
- KRYS $34.33
- IRT $4.19
- Revenue Next Year
- KRYS $48.04
- IRT $4.72
- P/E Ratio
- KRYS $29.71
- IRT $179.37
- Revenue Growth
- KRYS 54.51
- IRT 3.70
- 52 Week Low
- KRYS $122.80
- IRT $15.07
- 52 Week High
- KRYS $212.98
- IRT $22.26
- Technical
- Relative Strength Index (RSI)
- KRYS 59.19
- IRT 52.61
- Support Level
- KRYS $194.92
- IRT $15.99
- Resistance Level
- KRYS $212.98
- IRT $16.44
- Average True Range (ATR)
- KRYS 8.35
- IRT 0.36
- MACD
- KRYS -0.17
- IRT 0.07
- Stochastic Oscillator
- KRYS 42.14
- IRT 91.10
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.